Altium Capital Management LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001746382
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2024 · 66 positions · Total reported value $233.75M · Top-10 concentration 58.6% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 20.0% · 1 new · 3 cut · 0 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -5.1% · vs SPY -7.3% · Prev Value $47.47M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -1.2% · vs SPY -3.4% · Latest Value $68.81M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q2 2024 13F filing, Altium Capital Management LLC disclosed 66 equity positions with a combined reported value of $233.75M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 58.6% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.
The largest disclosed positions as of Q2 2024 were VERA ($25.83M), ADMA ($16.88M), XENE ($14.06M). By sector, the heaviest allocations are Health Care 74.3%, Consumer Discretionary 1.8%. Versus the prior quarter, allocation shifted toward Health Care (+2.9pp) and away from Other (-3.1pp).
Versus the prior quarter, Altium Capital Management LLC opened 1 new positions, trimmed 3 and fully exited 0, a turnover rate of 20.0% of positions. The portfolio's overlap with the prior quarter was 55% of names.
The largest new positions opened in Q2 2024 were SRPT ($12.94M), SKYE ($10.81M), ARGX ($9.89M).
Of the 8 positions fully exited versus the prior quarter, the largest were BHVN ($7.66M), OLMA ($6.85M), MIRM ($5.22M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2024)
- SRPT SAREPTA THERAPEUTICS INC · $12.94M
- SKYE SKYE BIOSCIENCE INC · $10.81M
- ARGX Argenx S.E. · $9.89M
- CTNM CONTINEUM THERAPEUTICS INC · $7.56M
- RZLT REZOLUTE INC · $7.31M
- MLTX MOONLAKE IMMUNOTHERAPEUTICS · $5.06M
- OTLK OUTLOOK THERAPEUTICS INC · $3.70M
- RARE ULTRAGENYX PHARMACEUTICAL IN · $2.88M
Fully Exited (vs previous quarter)
- BHVN BIOHAVEN LTD · prev qtr: $7.66M
- OLMA OLEMA PHARMACEUTICALS INC · prev qtr: $6.85M
- MIRM MIRUM PHARMACEUTICALS INC · prev qtr: $5.22M
- NGNE NEUROGENE INC · prev qtr: $5.09M
- PRAX PRAXIS PRECISION MEDICINES I · prev qtr: $4.77M
- LBPH LONGBOARD PHARMACEUTICALS IN · prev qtr: $3.67M
- ALPN ALPINE IMMUNE SCIENCES INC · prev qtr: $3.09M
- AQST AQUESTIVE THERAPEUTICS INC · prev qtr: $2.83M
Insider Transactions (Form 4)
Latest Altium Capital Management LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Altium Capital Management LLC is an SEC-registered 13F filer. As of Q2 2026 it reported 19 US equity positions with a combined value of $47.47M. HoldingsHub carries 11 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 19 positions · $47.47M reported value (Q2 2026)
- Top 10 holdings = 69.3% of reported value
- Largest position: RMT (ROYCE MICRO-CAP TR INC COM) at 8.6%
- Average position size: $2.50M
Sector Tilt
- Financials 91.6%
- Industrials 7.7%
- Health Care 0.7%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 6 added, 1 reduced
- 12 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
714.00K | $25.83M | 11.05% | Add | |
| 2 |
|
1.51M | $16.88M | 7.22% | Reduce | |
| 3 |
|
360.60K | $14.06M | 6.01% | Add | |
| 4 |
|
193.00K | $13.22M | 5.66% | Add | |
| 5 |
|
81.90K | $12.94M | 5.54% | New | |
| 6 |
|
190.00K | $12.73M | 5.45% | Add | |
| 7 |
|
2.15M | $11.95M | 5.11% | Reduce | |
| 8 |
|
1.35M | $10.81M | 4.63% | New | |
| 9 |
|
23.00K | $9.89M | 4.23% | New | |
| 10 |
|
212.91K | $8.69M | 3.72% | Add | |
| 11 |
|
610.00K | $8.58M | 3.67% | Add | |
| 12 |
|
500.00K | $7.75M | 3.31% | Hold | |
| 13 |
|
429.34K | $7.56M | 3.23% | New | |
| 14 |
|
1.70M | $7.31M | 3.13% | New | |
| 15 |
|
50.00K | $6.82M | 2.92% | Add | |
| 16 |
|
122.00K | $6.47M | 2.77% | Add | |
| 17 |
|
1.16M | $5.70M | 2.44% | Add | |
| 18 |
|
115.00K | $5.06M | 2.16% | New | |
| 19 |
|
7.42M | $4.67M | 2.00% | Reduce | |
| 20 |
|
50.00K | $4.03M | 1.72% | Reduce | |
| 21 |
|
1.25M | $3.99M | 1.71% | Add | |
| 22 |
|
13.95M | $3.78M | 1.62% | Hold | |
| 23 |
|
501.79K | $3.70M | 1.58% | New | |
| 24 |
|
70.00K | $2.88M | 1.23% | New | |
| 25 |
|
405.00K | $2.86M | 1.23% | Hold | |
| 26 |
|
2.28M | $1.92M | 0.82% | Add | |
| 27 |
|
191.45K | $1.91M | 0.82% | Reduce | |
| 28 |
|
196.00K | $1.42M | 0.61% | Reduce | |
| 29 |
|
1.01M | $1.34M | 0.57% | Reduce | |
| 30 |
|
216.31K | $1.02M | 0.43% | Reduce | |
| 31 |
|
969.84K | $967.51K | 0.41% | New | |
| 32 |
|
155.30K | $894.53K | 0.38% | New | |
| 33 |
|
1.98M | $793.93K | 0.34% | Reduce | |
| 34 |
|
360.00K | $721.80K | 0.31% | New | |
| 35 |
|
740.00K | $642.02K | 0.28% | Hold | |
| 36 |
|
200.00K | $610.00K | 0.26% | New | |
| 37 |
|
200.00K | $569.00K | 0.24% | Hold | |
| 38 |
|
137.20K | $558.39K | 0.24% | New | |
| 39 |
|
811.17K | $419.94K | 0.18% | Reduce | |
| 40 |
|
692.44K | $366.30K | 0.16% | Reduce | |
| 41 |
|
83.15K | $321.79K | 0.14% | Reduce | |
| 42 |
|
121.99K | $204.94K | 0.09% | New | |
| 43 |
|
83.91K | $161.10K | 0.07% | New | |
| 44 |
|
62.84K | $135.09K | 0.06% | Reduce | |
| 45 |
|
225.00K | $98.33K | 0.04% | Hold | |
| 46 |
|
20.00K | $80.60K | 0.03% | Reduce | |
| 47 |
|
339.96K | $74.79K | 0.03% | New | |
| 48 |
|
1.41M | $70.02K | 0.03% | Hold | |
| 49 |
|
103.13K | $59.81K | 0.03% | Add | |
| 50 |
|
200.00K | $49.76K | 0.02% | Hold | |
FAQ
What did Altium Capital Management LLC buy in 2024-Q2?
In its 2024-Q2 13F filing, Altium Capital Management LLC reported 66 equity positions worth $233.75M in aggregate; its largest disclosed positions were VERA ($25.83M), ADMA ($16.88M), XENE ($14.06M).
How large is Altium Capital Management LLC's portfolio?
Altium Capital Management LLC reported $233.75M of long equity holdings across 66 positions as of 2024-Q2. Top-10 holdings account for 58.6% of reported value.
What is Altium Capital Management LLC's investment style?
HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.